DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Ozguroglu M, Chowdhury S, Bjartell A. et al.
Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with low- and high-risk disease.
J Clin Oncol 2020;
38 (Suppl. 06) 87
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.